Join Cambridge Network and the Milner Therapeutics Institute to explore the world of genomics and AI in developing therapies for human disease. CRISPR gene-editing and AI are crucial tools in the early stages of developing therapies for the treatment of human disease. Such screens generate myriad datapoints that humans are unable to sift through without computational input.
Please join us to learn how the Milner Institute uses both approaches and wide-reaching collaborations input into all stages of the translational pathway from innovation through to patients and back.
Speakers:
Nicola McCarthy, Head of Research, Milner Therapeutics Institute
and
Namshik Han, Head of Computational Biology and Artificial Intelligence, Milner Therapeutics Institute
This event is free to attend for Milner affiliate companies, Milner Consortium members and Frame Shift companies and for current staff and students of the University of Cambridge and Anglia Ruskin University.
Please email louise.rushworth@cambridgenetwork.co.uk to sign up for free if you don't have a Cambridge Network member login.